LifeVantage Q3 net sales up 270%
The company has posted net loss of $9.77m, compared to $8.25m for the same period previous year. Gross profit was $8.39m, compared to $2.28m for the same period
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
OHR/AVR118 an immunomodulator which modulates cellular pro-inflammatory chemokine and cykotine synthesis, including tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). The company said OHR/AVR118 has powerful chemoprotective effects which
PharmaNet is a provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device industries and provides capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence